Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

J-P Courrèges; Tina Vilsbøll; M Zdravkovic; Xuan Le Thi Thanh; T Krarup; Ole Schmitz; R Verhoeven; I Bugáñová; S Madsbad

doi:http://dx.doi.org/10.1111/j.1464-5491.2008.02484.x

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

J-P Courrèges, Tina Vilsbøll, M Zdravkovic, Xuan Le Thi Thanh, T Krarup, Ole Schmitz, R Verhoeven, I Bugáñová, S Madsbad

Department of Clinical Medicine

169 Citations (Scopus)

Original language	English
Journal	Diabetic Medicine
Volume	25
Issue number	9
Pages (from-to)	1129-31
Number of pages	3
ISSN	0742-3071
DOIs	https://doi.org/10.1111/j.1464-5491.2008.02484.x
Publication status	Published - 1 Sept 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://dx.doi.org/10.1111/j.1464-5491.2008.02484.x

Cite this

Courrèges, J-P., Vilsbøll, T., Zdravkovic, M., Le Thi Thanh, X., Krarup, T., Schmitz, O., Verhoeven, R., Bugáñová, I., & Madsbad, S. (2008). Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes. Diabetic Medicine, 25(9), 1129-31. https://doi.org/10.1111/j.1464-5491.2008.02484.x

Courrèges, J-P, Vilsbøll, T, Zdravkovic, M, Le Thi Thanh, X, Krarup, T, Schmitz, O, Verhoeven, R, Bugáñová, I & Madsbad, S 2008, 'Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes', Diabetic Medicine, vol. 25, no. 9, pp. 1129-31. https://doi.org/10.1111/j.1464-5491.2008.02484.x

@article{5bd91833ba3744c9ae17f464c1850b58,

title = "Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes",

author = "J-P Courr{\`e}ges and Tina Vilsb{\o}ll and M Zdravkovic and {Le Thi Thanh}, Xuan and T Krarup and Ole Schmitz and R Verhoeven and I Bug{\'a}{\~n}ov{\'a} and S Madsbad",

year = "2008",

month = sep,

day = "1",

doi = "http://dx.doi.org/10.1111/j.1464-5491.2008.02484.x",

language = "English",

volume = "25",

pages = "1129--31",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell",

number = "9",

}

TY - JOUR

T1 - Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes

AU - Courrèges, J-P

AU - Vilsbøll, Tina

AU - Zdravkovic, M

AU - Le Thi Thanh, Xuan

AU - Krarup, T

AU - Schmitz, Ole

AU - Verhoeven, R

AU - Bugáñová, I

AU - Madsbad, S

PY - 2008/9/1

Y1 - 2008/9/1

U2 - http://dx.doi.org/10.1111/j.1464-5491.2008.02484.x

DO - http://dx.doi.org/10.1111/j.1464-5491.2008.02484.x

M3 - Journal article

SN - 0742-3071

VL - 25

SP - 1129

EP - 1131

JO - Diabetic Medicine

JF - Diabetic Medicine

IS - 9

ER -